1. Bartenschlager R, Lohmann V, Penin F. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. In: Nat Rev Microbiol. 2013 Jul;11(7):482-96. doi: https://doi.org/10.1038/nrmicro3046.
2. Bartenschlager R. (ed) Hepatitis C Virus: From Molecular Virology to Antiviral Therapy (Current Topics in Microbiology and Immunology, Band 369), Springer-Verlag, 2015
3. Blair, E.; Darby, G.; Gough, G.; Littler, E.; Rowlands, D.; Tinsdale, M. Antiviral Therapy. Oxford (BIOS Scientific Publishers) 1998.
4. Cameron, C. E.; Castro, C. The Mechanism of Action of Ribavirin: Lethal Mutagenesis of RNA Virus Genomes Mediated by the Viral RNA-Dependent RNA-Polymerase. In: Curr. Opin. Infect. Dis. 6 (2001) S. 757–764.
5. Darby, G. Only 35 Years of Antiviral Nucleoside Analogues. In: Hunter, P. A.; Darby, G. K.; Russell, N. J. (Hrsg.) Fifty Years of Antimicrobials: Past Perspectives and Future Trends. Cambridge (Cambridge University Press) 1996.